PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28100527-10 2017 Transcutaneous CO2 increased to a similar extent in both arms, with 2.4 (95% CI 0.5) mm Hg min-1 for the control arm and 2.4 (95% CI 0.4) mm Hg min-1 for the THRIVE arm. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 15-18 CD59 molecule (CD59 blood group) Homo sapiens 91-96 27783521-2 2016 By alternately bubbling CO2 and N2 at a moderate conditions (30 C, 80 mL min-1), silica nanoparticles reversibly switch between amphipathic and hydrophilic as a result of the adsorption of ammonium (CO2) and the desorption of tertiary amine (N2). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 24-27 CD59 molecule (CD59 blood group) Homo sapiens 74-79 25070608-6 2014 Mimicking oxyfuel operating conditions by switching argon to pure CO2 as a sweep gas at 1000 C and air as feed enabled an oxygen flux value of 5.6 mL min(-1) cm(-2) to be reached. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 66-69 CD59 molecule (CD59 blood group) Homo sapiens 151-157 25070608-9 2014 Finally, the membrane stability over a period of 150 h under CO2-rich sweep gas showed a low degradation rate of 2.4x10(-2) mL min(-1) cm(-2) per day. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 61-64 CD59 molecule (CD59 blood group) Homo sapiens 128-134 24901940-5 2014 Despite a partial decrease in oxygen permeation fluxes at 850 C, a steady state of 0.25 cm(3) (STP) min(-1) cm(-2) was reached and maintained for more than 100 h. The newly developed PSCF membrane also exhibited a higher oxygen permeation flux with He and CO2 sweeping at all measured temperatures compared to a similar La0.6Sr0.4Co0.8Fe0.2O3-delta (LSCF) membrane. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 257-260 CD59 molecule (CD59 blood group) Homo sapiens 101-107 26472918-3 2012 Mosquitoes are activated by brief exposure to a 1 L min-1 jet of 4% CO2 positioned 10 cm from the release cage. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 68-71 CD59 molecule (CD59 blood group) Homo sapiens 52-57 19660889-5 2009 Experimental conditions were 40 degrees C for temperature, 11 MPa for pressure, and a CO2 flow rate of 30 ml min(-1). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 86-89 CD59 molecule (CD59 blood group) Homo sapiens 109-115 10562352-14 1999 The peripheral chemoreflex sensitivity to CO2 in hypoxia was reduced from 2.42 +/- 0.36 to 1.18 +/- 0.20 l min-1 Torr-1 (P < 0.005) with somatostatin. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 42-45 CD59 molecule (CD59 blood group) Homo sapiens 107-112 8800358-3 1996 With 4% CO2, peak pulmonary ventilation during the exhaustive exercise increased further by 41 L min-1 (140-181 L min-1; P < 0.05) without affecting the handgrip strength. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 8-11 CD59 molecule (CD59 blood group) Homo sapiens 97-102 8800358-3 1996 With 4% CO2, peak pulmonary ventilation during the exhaustive exercise increased further by 41 L min-1 (140-181 L min-1; P < 0.05) without affecting the handgrip strength. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 8-11 CD59 molecule (CD59 blood group) Homo sapiens 114-119 8117632-7 1993 CO2-response curve slopes decreased from 1.84 +/- 0.54 to 1.40 +/- 0.58 l/min-1.mm Hg-1 (p < 0.05), and the curves were displaced 3.2 +/- 1.2 mm Hg to the right at 25 l/min-1 VE (p < 0.05). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 0-3 CD59 molecule (CD59 blood group) Homo sapiens 74-79 8117632-7 1993 CO2-response curve slopes decreased from 1.84 +/- 0.54 to 1.40 +/- 0.58 l/min-1.mm Hg-1 (p < 0.05), and the curves were displaced 3.2 +/- 1.2 mm Hg to the right at 25 l/min-1 VE (p < 0.05). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 0-3 CD59 molecule (CD59 blood group) Homo sapiens 172-177 1484352-9 1992 Following induction of inspiratory muscle fatigue, the slope of the ventilatory response to CO2 was significantly decreased from 18.8 +/- 3.3 during control to 13.8 +/- 2.1 l min-1 (% end-tidal CO2 concentration)-1 with fatigue (P < 0.02). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 92-95 CD59 molecule (CD59 blood group) Homo sapiens 175-180 1536404-6 1992 A 90% response to square wave changes of gas composition was maintained up to 60 breaths.min-1 for CO2, O2, and N2O and up to 40 breaths.min-1 for the vapours when the nafion sampling tube was used. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 99-102 CD59 molecule (CD59 blood group) Homo sapiens 89-94 2129130-3 1990 In this study PICO2 was measured to know the drug"s functioning time and CO2 elimination from the model lung fixed at 200 or 300 ml.min-1. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 16-19 CD59 molecule (CD59 blood group) Homo sapiens 132-137 3113526-4 1987 Specific CO2 reactivity (the change in flow per torr change in CO2) was 8.16 +/- 0.69 ml min-1 torr-1 which was equivalent to 2.0 +/- 0.1 per cent of the flow at 40 torr per torr change in CO2 (percentage CO2 reactivity). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 9-12 CD59 molecule (CD59 blood group) Homo sapiens 89-94 3113526-4 1987 Specific CO2 reactivity (the change in flow per torr change in CO2) was 8.16 +/- 0.69 ml min-1 torr-1 which was equivalent to 2.0 +/- 0.1 per cent of the flow at 40 torr per torr change in CO2 (percentage CO2 reactivity). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 63-66 CD59 molecule (CD59 blood group) Homo sapiens 89-94 3113526-4 1987 Specific CO2 reactivity (the change in flow per torr change in CO2) was 8.16 +/- 0.69 ml min-1 torr-1 which was equivalent to 2.0 +/- 0.1 per cent of the flow at 40 torr per torr change in CO2 (percentage CO2 reactivity). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 63-66 CD59 molecule (CD59 blood group) Homo sapiens 89-94 3113526-4 1987 Specific CO2 reactivity (the change in flow per torr change in CO2) was 8.16 +/- 0.69 ml min-1 torr-1 which was equivalent to 2.0 +/- 0.1 per cent of the flow at 40 torr per torr change in CO2 (percentage CO2 reactivity). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 63-66 CD59 molecule (CD59 blood group) Homo sapiens 89-94 3103662-2 1987 Ventilation with an FGF of 70 ml kg-1 min-1 produced mean PaCO2 and PE" CO2 values of 6.48 +/- 1.15 kPa and 6.41 +/- 0.76 kPa, respectively. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 60-63 CD59 molecule (CD59 blood group) Homo sapiens 38-43 3932321-9 1985 At a neutral TA, increasing inspired [CO2] to 6% resulted in a 6-breaths X min-1 increase in f during both NBr and TBr. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 38-41 CD59 molecule (CD59 blood group) Homo sapiens 75-80 6128020-3 1982 3 Noradrenaline 5.0 micrograms min-1 and isoprenaline 1.0 microgram min-1 significantly increased ventilation and CO2 production and decreased alveolar PCO2. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 114-117 CD59 molecule (CD59 blood group) Homo sapiens 31-57 6811529-6 1982 Ventilatory responses to rebreathing CO2 (6 subj) were 1.7 +/- 0.3 1 X min-1 X Torr-1 during W and 1.3 +/- 0.2 during SWS. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 37-40 CD59 molecule (CD59 blood group) Homo sapiens 71-102 468645-4 1979 The step-response time for the described system including a Beckman LB-2 CO2 analyzer, sampling tubing, and dryer is 120 ms at 1 l.min-1. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 73-76 CD59 molecule (CD59 blood group) Homo sapiens 131-136 32130637-5 2020 The maximum CO2 uptake rate of 182 mg L-1 day-1 was achieved for formulated flue gas flow rate above 100 mL min-1. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 12-15 CD59 molecule (CD59 blood group) Homo sapiens 108-113 31003568-6 2019 For the sample A1M1 calcined and completely rehydrated (Ca(OH)2), the chemical adsorption of CO2 to form CaCO3 is practically total, under the experimental conditions used (550 C and CO2 flow of 20 mL min-1). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 93-96 CD59 molecule (CD59 blood group) Homo sapiens 202-207 30637211-4 2018 Results: Added to the inspiration air at a flow rate of 2-3 Liter min-1, CO2 increased the respiratory volume up to 25-30 Liter min-1, ensuring forced AHH exhalation. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 73-76 CD59 molecule (CD59 blood group) Homo sapiens 66-71 30637211-4 2018 Results: Added to the inspiration air at a flow rate of 2-3 Liter min-1, CO2 increased the respiratory volume up to 25-30 Liter min-1, ensuring forced AHH exhalation. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 73-76 CD59 molecule (CD59 blood group) Homo sapiens 128-133 30193213-4 2018 Consequently, the dissolved CO2 concentration in the microalgae suspension of the proposed PBR was increased by 26.0% compared to that in the PBR without PIAT internals when 15% CO2 (v/v) was aerated at a rate of 15 mL min-1. N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 28-31 CD59 molecule (CD59 blood group) Homo sapiens 219-224 29502264-7 2018 CO was higher when inhaling O2-poor gas mixtures with or without CO2 (~ 17 L min-1) than in the other conditions (~ 14 L min-1, p < 0.001). N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)-4-((4-fluorobenzyl)oxy)pyridine-2,6-dicarboxamide 65-68 CD59 molecule (CD59 blood group) Homo sapiens 77-82